Pyxis Oncology
PYXS
PYXS
74 hedge funds and large institutions have $30.2M invested in Pyxis Oncology in 2025 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 20 increasing their positions, 23 reducing their positions, and 29 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
74
Holders Change
-14
Holders Change %
-15.91%
% of All Funds
0.99%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.01%
New
15
Increased
20
Reduced
23
Closed
29
Calls
$16K
Puts
$2K
Net Calls
+$14K
Net Calls Change
+$9K
Top Buyers
| 1 |
TCM
Tang Capital Management
San Diego,
California
|
$2.75M |
| 2 |
Millennium Management
New York
|
$3.89M |
| 3 |
Jane Street
New York
|
$370K |
| 4 |
SC
Schulhoff & Co
Cincinnati,
Ohio
|
$303K |
| 5 |
Marshall Wace
London,
United Kingdom
|
$163K |
Top Sellers
| 1 |
BlackRock
New York
|
$1.02M |
| 2 |
State Street
Boston,
Massachusetts
|
$205K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
$562K |
| 4 |
IC
Ikarian Capital
Dallas,
Texas
|
$0 |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
$2.36M |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
SCM
101
Sterling Capital Management
Charlotte,
North Carolina
| – | -$859 | -877 | Closed |
|
102
New York State Common Retirement Fund
Albany,
New York
| – | -$1K | -600 | Closed |
|
|
IA
103
IFP Advisors
Tampa,
Florida
| – | -$17 | -17 | Closed |
|